Therapeutic activity of bivalent BRD4 inhibitor AZD5153 in hematological cancers

被引：0

作者：

Chen, Huawei Ray

Hattersley, Maureen

Rhyasen, Garrett

Dulak, Austin

Wang, Wendy

Petteruti, Phil

Dale, Ian

Cheung, Tony

Wen, Shenghua

Castriotta, Lilian

Lawson, Deborah

Collins, Mike

Ahdesmaki, Miika

Walker, Graeme

Rabow, Al

Dry, Jonathan

Reimer, Corinne

Lyne, Paul

Fawell, Steve

Waring, Mike

Zinda, Mike

Clark, Ed

机构：

来源：

CANCER RESEARCH | 2016年 / 76卷

关键词：

D O I：

10.1158/1538-7445.AM2016-4705

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4705

引用

页数：3

共 50 条

[11] BRD4 as a Therapeutic Target in Pulmonary Diseases [J].

Guo, Xia ;

Olajuyin, Ayobami ;

Tucker, Torry A. ;

Idell, Steven ;

Qian, Guoqing .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)

[12] BRD4 is a novel therapeutic target in melanoma [J].

Segura, Miguel F. ;

Di Micco, Raffaella ;

Zhang, Guangtao ;

Zhang, Weijia ;

Osman, Iman ;

Zhou, Ming-Ming ;

Hernando, Eva .

CANCER RESEARCH, 2012, 72

[13] BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536 [J].

Chen, Lijia ;

Yap, Jeremy L. ;

Yoshioka, Makoto ;

Lanning, Maryanna E. ;

Fountain, Rachel N. ;

Raje, Mithun ;

Scheenstra, Jacob A. ;

Strovel, Jeffrey W. ;

Fletcher, Steven .

ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (07) :764-769

[14] BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL [J].

Lu, Jing ;

Qian, Yimin ;

Raina, Kanak ;

Altieri, Martha ;

Dong, Hanqing ;

Wang, Jing ;

Chen, Xin ;

Crew, Andrew ;

Coleman, Kevin ;

Crews, Craig ;

Winkler, James .

BLOOD, 2015, 126 (23)

[15] First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma [J].

Hamilton, Erika P. ;

Wang, Judy S. ;

Oza, Amit M. ;

Patel, Manish R. ;

Ulahannan, Susanna V. ;

Bauer, Todd ;

Karlix, Janet L. ;

Zeron-Medina, Jorge ;

Fabbri, Giulia ;

Marco-Casanova, Paola ;

Moorthy, Ganesh ;

Hattersley, Maureen M. ;

Littlewood, Gillian M. ;

Mitchell, Patrick ;

Saeh, Jamal ;

Pouliot, Gayle P. ;

Moore, Kathleen N. .

MOLECULAR CANCER THERAPEUTICS, 2023, 22 (10) :1154-1165

[16] BRD4 IS AN ENDOGENOUS INHIBITOR OF THE DNA DAMAGE RESPONSE [J].

不详 .

CANCER DISCOVERY, 2013, 3 (07) :718-718

[17] BRD4: An emerging prospective therapeutic target in glioma [J].

Yang, Hua ;

Li Wei ;

Xun, Yang ;

Yang, Anping ;

You, Hua .

MOLECULAR THERAPY-ONCOLYTICS, 2021, 21 :1-14

[18] BRD4 is a novel therapeutic target for liver fibrosis [J].

Ding, Ning ;

Hah, Nasun ;

Yu, Ruth T. ;

Sherman, Mara H. ;

Benner, Chris ;

Leblanc, Mathias ;

He, Mingxiao ;

Liddle, Christopher ;

Downes, Michael ;

Evans, Ronald M. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (51) :15713-15718

[19] BRD4 degradation by PROTACs represents a more effective therapeutic strategy than BRD4 inhibitors in ovarian cancer [J].

Raina, Kanak ;

Lu, Jing ;

Qian, Yimin ;

Altieri, Martha ;

Dong, Hanging ;

Wang, Jing ;

Chen, Xin ;

Crew, Andrew ;

Coleman, Kevin ;

Crews, Craig ;

Winkler, James .

CANCER RESEARCH, 2016, 76

[20] BRD4 Inhibitor Inhibits Colorectal Cancer Growth and Metastasis [J].

Hu, Yuan ;

Zhou, Jieqiong ;

Ye, Fei ;

Xiong, Huabao ;

Peng, Liang ;

Zheng, Zihan ;

Xu, Feihong ;

Cui, Miao ;

Wei, Chengguo ;

Wang, Xinying ;

Wang, Zhongqiu ;

Zhu, Hongfa ;

Lee, Peng ;

Zhou, Mingming ;

Jiang, Bo ;

Zhang, David Y. .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (01) :1928-1948

← 1 2 3 4 5 →